Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adherens junction 💬 12 genes, 24 drugs (DrugBank) and 29 diseases |
INSR [1] INSR 💬Adherens junction
|
Insulin human Insulin human 💬Adherens junction
| Insulin human | 156 [1] 156 💬1. Adherens junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
CACNA1C [5] CACNA1C, CACNA1D, CACNA1F, CACNA1S, SCN5A 💬Adrenergic signaling in cardiomyocytes |
Topiramate Topiramate 💬Adrenergic signaling in cardiomyocytes
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Alcoholism 💬 29 genes, 81 drugs (DrugBank) and 60 diseases |
DRD2 [1] DRD2 💬Alcoholism
|
Risperidone Risperidone 💬Alcoholism
| Risperidone | 008 [3] 8 , 156, 187 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Alcoholism 💬 29 genes, 81 drugs (DrugBank) and 60 diseases |
DRD2 [1] DRD2 💬Alcoholism
|
Sarizotan hydrochloride Sarizotan hydrochloride 💬Alcoholism
| Sarizotan | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Alcoholism 💬 29 genes, 81 drugs (DrugBank) and 60 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Alcoholism |
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Alcoholism
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬5. Alcoholism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Alcoholism 💬 29 genes, 81 drugs (DrugBank) and 60 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Alcoholism |
Dextromethorphan Dextromethorphan 💬Alcoholism
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬5. Alcoholism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Alcoholism 💬 29 genes, 81 drugs (DrugBank) and 60 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Alcoholism |
Esketamine Esketamine 💬Alcoholism
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬7. Alcoholism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Alcoholism 💬 29 genes, 81 drugs (DrugBank) and 60 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Alcoholism |
Esketamine hydrochloride Esketamine hydrochloride 💬Alcoholism
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬7. Alcoholism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Alcoholism 💬 29 genes, 81 drugs (DrugBank) and 60 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Alcoholism |
Ketamine hydrochloride Ketamine hydrochloride 💬Alcoholism
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬9. Alcoholism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Alcoholism 💬 29 genes, 81 drugs (DrugBank) and 60 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Alcoholism |
Ketamine Ketamine 💬Alcoholism
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬9. Alcoholism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | Aldosterone synthesis and secretion 💬 20 genes, 41 drugs (DrugBank) and 61 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Aldosterone synthesis and secretion
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | Aldosterone-regulated sodium reabsorption 💬 13 genes, 17 drugs (DrugBank) and 30 diseases |
INSR [1] INSR 💬Aldosterone-regulated sodium reabsorption
|
Insulin human Insulin human 💬Aldosterone-regulated sodium reabsorption
| Insulin human | 156 [1] 156 💬12. Aldosterone-regulated sodium reabsorption
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | Allograft rejection 💬 31 genes, 26 drugs (DrugBank) and 60 diseases |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬Allograft rejection
|
Glatiramer acetate Glatiramer acetate 💬Allograft rejection
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Alzheimer disease
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
CHRM1 [3] CHRM1, CHRM3, CHRM5 💬
|
Blarcamesine Blarcamesine 💬Alzheimer disease
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
CHRM1 [3] CHRM1, CHRM3, CHRM5 💬
|
Blarcamesine hydrochloride Blarcamesine hydrochloride 💬Alzheimer disease
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Alzheimer disease |
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Alzheimer disease
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬17. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Alzheimer disease |
Dextromethorphan Dextromethorphan 💬Alzheimer disease
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬17. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Alzheimer disease |
Esketamine Esketamine 💬Alzheimer disease
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬19. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Alzheimer disease |
Esketamine hydrochloride Esketamine hydrochloride 💬Alzheimer disease
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬19. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Alzheimer disease |
Ketamine hydrochloride Ketamine hydrochloride 💬Alzheimer disease
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬21. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Alzheimer disease |
Ketamine Ketamine 💬Alzheimer disease
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬21. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
INSR [1] INSR 💬Alzheimer disease
|
Insulin human Insulin human 💬Alzheimer disease
| Insulin human | 156 [1] 156 💬23. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
CACNA1C [6] CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4 💬Amphetamine addiction
|
Topiramate Topiramate 💬Amphetamine addiction
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Amphetamine addiction |
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Amphetamine addiction
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬25. Amphetamine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Amphetamine addiction |
Dextromethorphan Dextromethorphan 💬Amphetamine addiction
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬25. Amphetamine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Amphetamine addiction |
Esketamine Esketamine 💬Amphetamine addiction
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬27. Amphetamine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Amphetamine addiction |
Esketamine hydrochloride Esketamine hydrochloride 💬Amphetamine addiction
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬27. Amphetamine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Amphetamine addiction |
Ketamine hydrochloride Ketamine hydrochloride 💬Amphetamine addiction
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬29. Amphetamine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Amphetamine addiction |
Ketamine Ketamine 💬Amphetamine addiction
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬29. Amphetamine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 | AMPK signaling pathway 💬 16 genes, 56 drugs (DrugBank) and 95 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Lovastatin Lovastatin 💬AMPK signaling pathway
| Lovastatin | 006 [11] 6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬31. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | AMPK signaling pathway 💬 16 genes, 56 drugs (DrugBank) and 95 diseases |
INSR [1] INSR 💬AMPK signaling pathway
|
Insulin human Insulin human 💬AMPK signaling pathway
| Insulin human | 156 [1] 156 💬32. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | Amyotrophic lateral sclerosis 💬 38 genes, 55 drugs (DrugBank) and 109 diseases |
GRIA1 [2] GRIA1, GRIA2 💬
|
Topiramate Topiramate 💬Amyotrophic lateral sclerosis
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | Amyotrophic lateral sclerosis 💬 38 genes, 55 drugs (DrugBank) and 109 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Amyotrophic lateral sclerosis |
Esketamine Esketamine 💬Amyotrophic lateral sclerosis
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬34. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | Amyotrophic lateral sclerosis 💬 38 genes, 55 drugs (DrugBank) and 109 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Amyotrophic lateral sclerosis |
Esketamine hydrochloride Esketamine hydrochloride 💬Amyotrophic lateral sclerosis
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬34. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | Amyotrophic lateral sclerosis 💬 38 genes, 55 drugs (DrugBank) and 109 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Amyotrophic lateral sclerosis |
Ketamine hydrochloride Ketamine hydrochloride 💬Amyotrophic lateral sclerosis
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬36. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | Amyotrophic lateral sclerosis 💬 38 genes, 55 drugs (DrugBank) and 109 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Amyotrophic lateral sclerosis |
Ketamine Ketamine 💬Amyotrophic lateral sclerosis
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬36. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 38 | Amyotrophic lateral sclerosis 💬 38 genes, 55 drugs (DrugBank) and 109 diseases |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬Amyotrophic lateral sclerosis
|
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Amyotrophic lateral sclerosis
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬38. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 39 | Amyotrophic lateral sclerosis 💬 38 genes, 55 drugs (DrugBank) and 109 diseases |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬Amyotrophic lateral sclerosis
|
Dextromethorphan Dextromethorphan 💬Amyotrophic lateral sclerosis
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬38. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 40 | Amyotrophic lateral sclerosis 💬 38 genes, 55 drugs (DrugBank) and 109 diseases |
SIGMAR1 [1] SIGMAR1 💬Amyotrophic lateral sclerosis
|
Blarcamesine Blarcamesine 💬Amyotrophic lateral sclerosis
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 41 | Amyotrophic lateral sclerosis 💬 38 genes, 55 drugs (DrugBank) and 109 diseases |
SIGMAR1 [1] SIGMAR1 💬Amyotrophic lateral sclerosis
|
Blarcamesine hydrochloride Blarcamesine hydrochloride 💬Amyotrophic lateral sclerosis
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 42 | Antigen processing and presentation 💬 26 genes, 17 drugs (DrugBank) and 61 diseases |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬Antigen processing and presentation
|
Glatiramer acetate Glatiramer acetate 💬Antigen processing and presentation
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 43 | Arrhythmogenic right ventricular cardiomyopathy 💬 15 genes, 30 drugs (DrugBank) and 28 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Arrhythmogenic right ventricular cardiomyopathy
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 44 | Asthma 💬 21 genes, 25 drugs (DrugBank) and 58 diseases |
HLA-DMA [14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 💬Asthma
|
Glatiramer acetate Glatiramer acetate 💬Asthma
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 45 | Autoimmune thyroid disease 💬 42 genes, 18 drugs (DrugBank) and 37 diseases |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬Autoimmune thyroid disease
|
Glatiramer acetate Glatiramer acetate 💬Autoimmune thyroid disease
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 46 | Bile secretion 💬 14 genes, 36 drugs (DrugBank) and 61 diseases |
CA2 [1] CA2 💬Bile secretion
|
Topiramate Topiramate 💬Bile secretion
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 47 | Bile secretion 💬 14 genes, 36 drugs (DrugBank) and 61 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Lovastatin Lovastatin 💬Bile secretion
| Lovastatin | 006 [11] 6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬47. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 48 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Calcium signaling pathway
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 49 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
CHRM1 [4] CHRM1, CHRM2, CHRM3, CHRM5 💬
|
Blarcamesine Blarcamesine 💬Calcium signaling pathway
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 50 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
CHRM1 [4] CHRM1, CHRM2, CHRM3, CHRM5 💬
|
Blarcamesine hydrochloride Blarcamesine hydrochloride 💬Calcium signaling pathway
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 51 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Calcium signaling pathway |
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Calcium signaling pathway
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬51. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 52 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Calcium signaling pathway |
Dextromethorphan Dextromethorphan 💬Calcium signaling pathway
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬51. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 53 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Calcium signaling pathway |
Esketamine Esketamine 💬Calcium signaling pathway
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬53. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 54 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Calcium signaling pathway |
Esketamine hydrochloride Esketamine hydrochloride 💬Calcium signaling pathway
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬53. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 55 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Calcium signaling pathway |
Ketamine hydrochloride Ketamine hydrochloride 💬Calcium signaling pathway
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬55. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 56 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Calcium signaling pathway |
Ketamine Ketamine 💬Calcium signaling pathway
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬55. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 57 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
HTR2A [1] HTR2A 💬Calcium signaling pathway
|
Risperidone Risperidone 💬Calcium signaling pathway
| Risperidone | 008 [3] 8 , 156, 187 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 58 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
CACNA1C [8] CACNA1C, CACNA1D, CACNA1F, CACNA1S, GRIA1, GRIA2, GRIA3, GRIA4 💬cAMP signaling pathway
|
Topiramate Topiramate 💬cAMP signaling pathway
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 59 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
CHRM1 [2] CHRM1, CHRM2 💬
|
Blarcamesine Blarcamesine 💬cAMP signaling pathway
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 60 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
CHRM1 [2] CHRM1, CHRM2 💬
|
Blarcamesine hydrochloride Blarcamesine hydrochloride 💬cAMP signaling pathway
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 61 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
DRD2 [1] DRD2 💬cAMP signaling pathway
|
Risperidone Risperidone 💬cAMP signaling pathway
| Risperidone | 008 [3] 8 , 156, 187 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 62 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
DRD2 [2] DRD2, HTR1A 💬
|
Sarizotan hydrochloride Sarizotan hydrochloride 💬cAMP signaling pathway
| Sarizotan | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 63 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬cAMP signaling pathway |
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬cAMP signaling pathway
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬63. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 64 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬cAMP signaling pathway |
Dextromethorphan Dextromethorphan 💬cAMP signaling pathway
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬63. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 65 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬cAMP signaling pathway |
Esketamine Esketamine 💬cAMP signaling pathway
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬65. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 66 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬cAMP signaling pathway |
Esketamine hydrochloride Esketamine hydrochloride 💬cAMP signaling pathway
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬65. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 67 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬cAMP signaling pathway |
Ketamine hydrochloride Ketamine hydrochloride 💬cAMP signaling pathway
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬67. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 68 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬cAMP signaling pathway |
Ketamine Ketamine 💬cAMP signaling pathway
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬67. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 69 | Carbohydrate digestion and absorption 💬 13 genes, 21 drugs (DrugBank) and 33 diseases |
CACNA1D [1] CACNA1D 💬Carbohydrate digestion and absorption
|
Topiramate Topiramate 💬Carbohydrate digestion and absorption
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 70 | Cardiac muscle contraction 💬 17 genes, 20 drugs (DrugBank) and 25 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Cardiac muscle contraction
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 71 | Cell adhesion molecules 💬 43 genes, 34 drugs (DrugBank) and 43 diseases |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬Cell adhesion molecules
|
Glatiramer acetate Glatiramer acetate 💬Cell adhesion molecules
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 72 | Cellular senescence 💬 34 genes, 46 drugs (DrugBank) and 96 diseases |
CACNA1D [1] CACNA1D 💬Cellular senescence
|
Topiramate Topiramate 💬Cellular senescence
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 73 | Cellular senescence 💬 34 genes, 46 drugs (DrugBank) and 96 diseases |
HLA-A [6] HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G 💬Cellular senescence
|
Glatiramer acetate Glatiramer acetate 💬Cellular senescence
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 74 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬cGMP-PKG signaling pathway
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 75 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
INSR [1] INSR 💬cGMP-PKG signaling pathway
|
Insulin human Insulin human 💬cGMP-PKG signaling pathway
| Insulin human | 156 [1] 156 💬75. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 76 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Chemical carcinogenesis - receptor activation
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 77 | Cholinergic synapse 💬 32 genes, 64 drugs (DrugBank) and 81 diseases |
ACHE [1] ACHE 💬Cholinergic synapse
|
Donepezil hydrochloride Donepezil hydrochloride 💬Cholinergic synapse
| Donepezil | 005 [8] 5 , 6 , 13, 46, 124, 127, 156, 206 💬77. Cholinergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 78 | Cholinergic synapse 💬 32 genes, 64 drugs (DrugBank) and 81 diseases |
ACHE [1] ACHE 💬Cholinergic synapse
|
Donepezil Donepezil 💬Cholinergic synapse
| Donepezil | 005 [8] 5 , 6 , 13, 46, 124, 127, 156, 206 💬77. Cholinergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 79 | Cholinergic synapse 💬 32 genes, 64 drugs (DrugBank) and 81 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Cholinergic synapse
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 80 | Cholinergic synapse 💬 32 genes, 64 drugs (DrugBank) and 81 diseases |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
|
Blarcamesine Blarcamesine 💬Cholinergic synapse
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 81 | Cholinergic synapse 💬 32 genes, 64 drugs (DrugBank) and 81 diseases |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
|
Blarcamesine hydrochloride Blarcamesine hydrochloride 💬Cholinergic synapse
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 82 | Circadian entrainment 💬 23 genes, 39 drugs (DrugBank) and 55 diseases |
CACNA1C [6] CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4 💬Circadian entrainment
|
Topiramate Topiramate 💬Circadian entrainment
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 83 | Circadian entrainment 💬 23 genes, 39 drugs (DrugBank) and 55 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Circadian entrainment |
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Circadian entrainment
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬83. Circadian entrainment
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 84 | Circadian entrainment 💬 23 genes, 39 drugs (DrugBank) and 55 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Circadian entrainment |
Dextromethorphan Dextromethorphan 💬Circadian entrainment
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬83. Circadian entrainment
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 85 | Circadian entrainment 💬 23 genes, 39 drugs (DrugBank) and 55 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Circadian entrainment |
Esketamine Esketamine 💬Circadian entrainment
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬85. Circadian entrainment
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 86 | Circadian entrainment 💬 23 genes, 39 drugs (DrugBank) and 55 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Circadian entrainment |
Esketamine hydrochloride Esketamine hydrochloride 💬Circadian entrainment
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬85. Circadian entrainment
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 87 | Circadian entrainment 💬 23 genes, 39 drugs (DrugBank) and 55 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Circadian entrainment |
Ketamine hydrochloride Ketamine hydrochloride 💬Circadian entrainment
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬87. Circadian entrainment
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 88 | Circadian entrainment 💬 23 genes, 39 drugs (DrugBank) and 55 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Circadian entrainment |
Ketamine Ketamine 💬Circadian entrainment
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬87. Circadian entrainment
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 89 | Cocaine addiction 💬 15 genes, 66 drugs (DrugBank) and 54 diseases |
DRD2 [1] DRD2 💬Cocaine addiction
|
Risperidone Risperidone 💬Cocaine addiction
| Risperidone | 008 [3] 8 , 156, 187 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 90 | Cocaine addiction 💬 15 genes, 66 drugs (DrugBank) and 54 diseases |
DRD2 [1] DRD2 💬Cocaine addiction
|
Sarizotan hydrochloride Sarizotan hydrochloride 💬Cocaine addiction
| Sarizotan | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 91 | Cocaine addiction 💬 15 genes, 66 drugs (DrugBank) and 54 diseases |
GRIA2 [1] GRIA2 💬Cocaine addiction
|
Topiramate Topiramate 💬Cocaine addiction
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 92 | Cocaine addiction 💬 15 genes, 66 drugs (DrugBank) and 54 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Cocaine addiction |
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Cocaine addiction
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬92. Cocaine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 93 | Cocaine addiction 💬 15 genes, 66 drugs (DrugBank) and 54 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Cocaine addiction |
Dextromethorphan Dextromethorphan 💬Cocaine addiction
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬92. Cocaine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 94 | Cocaine addiction 💬 15 genes, 66 drugs (DrugBank) and 54 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Cocaine addiction |
Esketamine Esketamine 💬Cocaine addiction
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬94. Cocaine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 95 | Cocaine addiction 💬 15 genes, 66 drugs (DrugBank) and 54 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Cocaine addiction |
Esketamine hydrochloride Esketamine hydrochloride 💬Cocaine addiction
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬94. Cocaine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 96 | Cocaine addiction 💬 15 genes, 66 drugs (DrugBank) and 54 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Cocaine addiction |
Ketamine hydrochloride Ketamine hydrochloride 💬Cocaine addiction
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬96. Cocaine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 97 | Cocaine addiction 💬 15 genes, 66 drugs (DrugBank) and 54 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Cocaine addiction |
Ketamine Ketamine 💬Cocaine addiction
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬96. Cocaine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 98 | Collecting duct acid secretion 💬 3 genes, 11 drugs (DrugBank) and 34 diseases |
CA2 [1] CA2 💬Collecting duct acid secretion
|
Topiramate Topiramate 💬Collecting duct acid secretion
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 99 | Cortisol synthesis and secretion 💬 15 genes, 36 drugs (DrugBank) and 63 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Cortisol synthesis and secretion
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 100 | Cushing syndrome 💬 24 genes, 55 drugs (DrugBank) and 71 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Cushing syndrome
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 101 | Cytokine-cytokine receptor interaction 💬 89 genes, 142 drugs (DrugBank) and 110 diseases |
GHR [1] GHR 💬Cytokine-cytokine receptor interaction
|
Somatropin Somatropin 💬Cytokine-cytokine receptor interaction
| Somatotropin | 002 [28] 2 , 3 , 13, 19, 36, 46, 65, 74, 75, 76, 77, 78, 96, 97, 107, 113, 156, 187, 191, 193, 195, 238, 246, 265, 274, 276, 299, 337 💬101. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 102 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
INSR [1] INSR 💬Diabetic cardiomyopathy
|
Insulin human Insulin human 💬Diabetic cardiomyopathy
| Insulin human | 156 [1] 156 💬102. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 103 | Dilated cardiomyopathy 💬 24 genes, 61 drugs (DrugBank) and 88 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Dilated cardiomyopathy
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 104 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
CACNA1C [7] CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4, SCN1A 💬Dopaminergic synapse
|
Topiramate Topiramate 💬Dopaminergic synapse
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 105 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
DRD2 [1] DRD2 💬Dopaminergic synapse
|
Risperidone Risperidone 💬Dopaminergic synapse
| Risperidone | 008 [3] 8 , 156, 187 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 106 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
DRD2 [1] DRD2 💬Dopaminergic synapse
|
Sarizotan hydrochloride Sarizotan hydrochloride 💬Dopaminergic synapse
| Sarizotan | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 107 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
GRIN2A [2] GRIN2A, GRIN2B 💬
|
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Dopaminergic synapse
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬107. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 108 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
GRIN2A [2] GRIN2A, GRIN2B 💬
|
Dextromethorphan Dextromethorphan 💬Dopaminergic synapse
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬107. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 109 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
GRIN2A [2] GRIN2A, GRIN2B 💬
|
Esketamine Esketamine 💬Dopaminergic synapse
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬109. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 110 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
GRIN2A [2] GRIN2A, GRIN2B 💬
|
Esketamine hydrochloride Esketamine hydrochloride 💬Dopaminergic synapse
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬109. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 111 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
GRIN2A [2] GRIN2A, GRIN2B 💬
|
Ketamine hydrochloride Ketamine hydrochloride 💬Dopaminergic synapse
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬111. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 112 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
GRIN2A [2] GRIN2A, GRIN2B 💬
|
Ketamine Ketamine 💬Dopaminergic synapse
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬111. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 113 | Efferocytosis 💬 29 genes, 74 drugs (DrugBank) and 93 diseases |
S1PR1 [1] S1PR1 💬Efferocytosis
|
Fingolimod hydrochloride Fingolimod hydrochloride 💬Efferocytosis
| Fingolimod | 013 [3] 13, 14, 156 💬113. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 114 | Efferocytosis 💬 29 genes, 74 drugs (DrugBank) and 93 diseases |
S1PR1 [1] S1PR1 💬Efferocytosis
|
Fingolimod Fingolimod 💬Efferocytosis
| Fingolimod | 013 [3] 13, 14, 156 💬113. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 115 | Efferocytosis 💬 29 genes, 74 drugs (DrugBank) and 93 diseases |
S1PR1 [1] S1PR1 💬Efferocytosis
|
Fingolimod lauryl sulfate Fingolimod lauryl sulfate 💬Efferocytosis
| Fingolimod | 013 [3] 13, 14, 156 💬113. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 116 | Endocytosis 💬 22 genes, 37 drugs (DrugBank) and 54 diseases |
HLA-A [6] HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G 💬Endocytosis
|
Glatiramer acetate Glatiramer acetate 💬Endocytosis
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 117 | Epstein-Barr virus infection 💬 67 genes, 90 drugs (DrugBank) and 82 diseases |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬Epstein-Barr virus infection
|
Glatiramer acetate Glatiramer acetate 💬Epstein-Barr virus infection
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 118 | FoxO signaling pathway 💬 25 genes, 43 drugs (DrugBank) and 60 diseases |
INSR [1] INSR 💬FoxO signaling pathway
|
Insulin human Insulin human 💬FoxO signaling pathway
| Insulin human | 156 [1] 156 💬118. FoxO signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 119 | FoxO signaling pathway 💬 25 genes, 43 drugs (DrugBank) and 60 diseases |
S1PR1 [1] S1PR1 💬FoxO signaling pathway
|
Fingolimod hydrochloride Fingolimod hydrochloride 💬FoxO signaling pathway
| Fingolimod | 013 [3] 13, 14, 156 💬119. FoxO signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 120 | FoxO signaling pathway 💬 25 genes, 43 drugs (DrugBank) and 60 diseases |
S1PR1 [1] S1PR1 💬FoxO signaling pathway
|
Fingolimod Fingolimod 💬FoxO signaling pathway
| Fingolimod | 013 [3] 13, 14, 156 💬119. FoxO signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 121 | FoxO signaling pathway 💬 25 genes, 43 drugs (DrugBank) and 60 diseases |
S1PR1 [1] S1PR1 💬FoxO signaling pathway
|
Fingolimod lauryl sulfate Fingolimod lauryl sulfate 💬FoxO signaling pathway
| Fingolimod | 013 [3] 13, 14, 156 💬119. FoxO signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 122 | GABAergic synapse 💬 29 genes, 43 drugs (DrugBank) and 55 diseases |
CACNA1C [20] CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬GABAergic synapse
|
Topiramate Topiramate 💬GABAergic synapse
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 123 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
DRD2 [1] DRD2 💬Gap junction
|
Sarizotan hydrochloride Sarizotan hydrochloride 💬Gap junction
| Sarizotan | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 124 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
DRD2 [2] DRD2, HTR2A 💬
|
Risperidone Risperidone 💬Gap junction
| Risperidone | 008 [3] 8 , 156, 187 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 125 | Gastric acid secretion 💬 14 genes, 55 drugs (DrugBank) and 63 diseases |
CA2 [1] CA2 💬Gastric acid secretion
|
Topiramate Topiramate 💬Gastric acid secretion
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 126 | Gastric acid secretion 💬 14 genes, 55 drugs (DrugBank) and 63 diseases |
CHRM3 [1] CHRM3 💬Gastric acid secretion
|
Blarcamesine Blarcamesine 💬Gastric acid secretion
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 127 | Gastric acid secretion 💬 14 genes, 55 drugs (DrugBank) and 63 diseases |
CHRM3 [1] CHRM3 💬Gastric acid secretion
|
Blarcamesine hydrochloride Blarcamesine hydrochloride 💬Gastric acid secretion
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 128 | Glutamatergic synapse 💬 23 genes, 30 drugs (DrugBank) and 81 diseases |
CACNA1C [11] CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5 💬Glutamatergic synapse
|
Topiramate Topiramate 💬Glutamatergic synapse
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 129 | Glutamatergic synapse 💬 23 genes, 30 drugs (DrugBank) and 81 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Glutamatergic synapse |
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Glutamatergic synapse
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬129. Glutamatergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 130 | Glutamatergic synapse 💬 23 genes, 30 drugs (DrugBank) and 81 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Glutamatergic synapse |
Dextromethorphan Dextromethorphan 💬Glutamatergic synapse
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬129. Glutamatergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 131 | Glutamatergic synapse 💬 23 genes, 30 drugs (DrugBank) and 81 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Glutamatergic synapse |
Esketamine Esketamine 💬Glutamatergic synapse
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬131. Glutamatergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 132 | Glutamatergic synapse 💬 23 genes, 30 drugs (DrugBank) and 81 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Glutamatergic synapse |
Esketamine hydrochloride Esketamine hydrochloride 💬Glutamatergic synapse
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬131. Glutamatergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 133 | Glutamatergic synapse 💬 23 genes, 30 drugs (DrugBank) and 81 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Glutamatergic synapse |
Ketamine hydrochloride Ketamine hydrochloride 💬Glutamatergic synapse
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬133. Glutamatergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 134 | Glutamatergic synapse 💬 23 genes, 30 drugs (DrugBank) and 81 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Glutamatergic synapse |
Ketamine Ketamine 💬Glutamatergic synapse
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬133. Glutamatergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 135 | Glycerophospholipid metabolism 💬 1 gene, 7 drugs (DrugBank) and 14 diseases |
ACHE [1] ACHE 💬Glycerophospholipid metabolism
|
Donepezil hydrochloride Donepezil hydrochloride 💬Glycerophospholipid metabolism
| Donepezil | 005 [8] 5 , 6 , 13, 46, 124, 127, 156, 206 💬135. Glycerophospholipid metabolism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 136 | Glycerophospholipid metabolism 💬 1 gene, 7 drugs (DrugBank) and 14 diseases |
ACHE [1] ACHE 💬Glycerophospholipid metabolism
|
Donepezil Donepezil 💬Glycerophospholipid metabolism
| Donepezil | 005 [8] 5 , 6 , 13, 46, 124, 127, 156, 206 💬135. Glycerophospholipid metabolism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 137 | GnRH secretion 💬 22 genes, 47 drugs (DrugBank) and 56 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬GnRH secretion
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 138 | GnRH signaling pathway 💬 16 genes, 40 drugs (DrugBank) and 42 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬GnRH signaling pathway
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 139 | Graft-versus-host disease 💬 28 genes, 25 drugs (DrugBank) and 64 diseases |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬Graft-versus-host disease
|
Glatiramer acetate Glatiramer acetate 💬Graft-versus-host disease
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 140 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 100 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Growth hormone synthesis, secretion and action
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 141 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 100 diseases |
GHR [1] GHR 💬Growth hormone synthesis, secretion and action
|
Somatropin Somatropin 💬Growth hormone synthesis, secretion and action
| Somatotropin | 002 [28] 2 , 3 , 13, 19, 36, 46, 65, 74, 75, 76, 77, 78, 96, 97, 107, 113, 156, 187, 191, 193, 195, 238, 246, 265, 274, 276, 299, 337 💬141. Growth hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 142 | Hematopoietic cell lineage 💬 53 genes, 95 drugs (DrugBank) and 101 diseases |
HLA-DMA [14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 💬Hematopoietic cell lineage
|
Glatiramer acetate Glatiramer acetate 💬Hematopoietic cell lineage
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 143 | Herpes simplex virus 1 infection 💬 70 genes, 80 drugs (DrugBank) and 107 diseases |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬Herpes simplex virus 1 infection
|
Glatiramer acetate Glatiramer acetate 💬Herpes simplex virus 1 infection
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 144 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
INSR [1] INSR 💬HIF-1 signaling pathway
|
Insulin human Insulin human 💬HIF-1 signaling pathway
| Insulin human | 156 [1] 156 💬144. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 145 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
DRD2 [1] DRD2 💬Hormone signaling
|
Risperidone Risperidone 💬Hormone signaling
| Risperidone | 008 [3] 8 , 156, 187 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 146 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
DRD2 [1] DRD2 💬Hormone signaling
|
Sarizotan hydrochloride Sarizotan hydrochloride 💬Hormone signaling
| Sarizotan | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 147 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
GHR [1] GHR 💬Hormone signaling
|
Somatropin Somatropin 💬Hormone signaling
| Somatotropin | 002 [28] 2 , 3 , 13, 19, 36, 46, 65, 74, 75, 76, 77, 78, 96, 97, 107, 113, 156, 187, 191, 193, 195, 238, 246, 265, 274, 276, 299, 337 💬147. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 148 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
INSR [1] INSR 💬Hormone signaling
|
Insulin human Insulin human 💬Hormone signaling
| Insulin human | 156 [1] 156 💬148. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 149 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
HLA-A [6] HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G 💬Human cytomegalovirus infection
|
Glatiramer acetate Glatiramer acetate 💬Human cytomegalovirus infection
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 150 | Human immunodeficiency virus 1 infection 💬 50 genes, 57 drugs (DrugBank) and 95 diseases |
HLA-A [6] HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G 💬Human immunodeficiency virus 1 infection
|
Glatiramer acetate Glatiramer acetate 💬Human immunodeficiency virus 1 infection
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 151 | Human papillomavirus infection 💬 51 genes, 106 drugs (DrugBank) and 115 diseases |
HLA-A [6] HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G 💬Human papillomavirus infection
|
Glatiramer acetate Glatiramer acetate 💬Human papillomavirus infection
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 152 | Human T-cell leukemia virus 1 infection 💬 59 genes, 74 drugs (DrugBank) and 96 diseases |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬Human T-cell leukemia virus 1 infection
|
Glatiramer acetate Glatiramer acetate 💬Human T-cell leukemia virus 1 infection
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 153 | Huntington disease 💬 26 genes, 39 drugs (DrugBank) and 87 diseases |
GRIA1 [4] GRIA1, GRIA2, GRIA3, GRIA4 💬
|
Topiramate Topiramate 💬Huntington disease
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 154 | Huntington disease 💬 26 genes, 39 drugs (DrugBank) and 87 diseases |
GRIN1 [2] GRIN1, GRIN2B 💬
|
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Huntington disease
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬154. Huntington disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 155 | Huntington disease 💬 26 genes, 39 drugs (DrugBank) and 87 diseases |
GRIN1 [2] GRIN1, GRIN2B 💬
|
Dextromethorphan Dextromethorphan 💬Huntington disease
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬154. Huntington disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 156 | Huntington disease 💬 26 genes, 39 drugs (DrugBank) and 87 diseases |
GRIN1 [2] GRIN1, GRIN2B 💬
|
Esketamine Esketamine 💬Huntington disease
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬156. Huntington disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 157 | Huntington disease 💬 26 genes, 39 drugs (DrugBank) and 87 diseases |
GRIN1 [2] GRIN1, GRIN2B 💬
|
Esketamine hydrochloride Esketamine hydrochloride 💬Huntington disease
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬156. Huntington disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 158 | Huntington disease 💬 26 genes, 39 drugs (DrugBank) and 87 diseases |
GRIN1 [2] GRIN1, GRIN2B 💬
|
Ketamine hydrochloride Ketamine hydrochloride 💬Huntington disease
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬158. Huntington disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 159 | Huntington disease 💬 26 genes, 39 drugs (DrugBank) and 87 diseases |
GRIN1 [2] GRIN1, GRIN2B 💬
|
Ketamine Ketamine 💬Huntington disease
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬158. Huntington disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 160 | Hypertrophic cardiomyopathy 💬 27 genes, 57 drugs (DrugBank) and 90 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Hypertrophic cardiomyopathy
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 161 | Inflammatory bowel disease 💬 37 genes, 46 drugs (DrugBank) and 70 diseases |
HLA-DMA [14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 💬Inflammatory bowel disease
|
Glatiramer acetate Glatiramer acetate 💬Inflammatory bowel disease
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 162 | Inflammatory mediator regulation of TRP channels 💬 25 genes, 53 drugs (DrugBank) and 65 diseases |
HTR2A [1] HTR2A 💬Inflammatory mediator regulation of TRP channels
|
Risperidone Risperidone 💬Inflammatory mediator regulation of TRP channels
| Risperidone | 008 [3] 8 , 156, 187 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 163 | Influenza A 💬 65 genes, 78 drugs (DrugBank) and 98 diseases |
HLA-DMA [14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 💬Influenza A
|
Glatiramer acetate Glatiramer acetate 💬Influenza A
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 164 | Insulin resistance 💬 19 genes, 38 drugs (DrugBank) and 100 diseases |
INSR [1] INSR 💬Insulin resistance
|
Insulin human Insulin human 💬Insulin resistance
| Insulin human | 156 [1] 156 💬164. Insulin resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 165 | Insulin secretion 💬 15 genes, 48 drugs (DrugBank) and 51 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Insulin secretion
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 166 | Insulin secretion 💬 15 genes, 48 drugs (DrugBank) and 51 diseases |
CHRM3 [1] CHRM3 💬Insulin secretion
|
Blarcamesine Blarcamesine 💬Insulin secretion
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 167 | Insulin secretion 💬 15 genes, 48 drugs (DrugBank) and 51 diseases |
CHRM3 [1] CHRM3 💬Insulin secretion
|
Blarcamesine hydrochloride Blarcamesine hydrochloride 💬Insulin secretion
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 168 | Insulin signaling pathway 💬 12 genes, 28 drugs (DrugBank) and 71 diseases |
INSR [1] INSR 💬Insulin signaling pathway
|
Insulin human Insulin human 💬Insulin signaling pathway
| Insulin human | 156 [1] 156 💬168. Insulin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 169 | Intestinal immune network for IgA production 💬 33 genes, 40 drugs (DrugBank) and 51 diseases |
HLA-DMA [14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 💬Intestinal immune network for IgA production
|
Glatiramer acetate Glatiramer acetate 💬Intestinal immune network for IgA production
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 170 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
GHR [1] GHR 💬JAK-STAT signaling pathway
|
Somatropin Somatropin 💬JAK-STAT signaling pathway
| Somatotropin | 002 [28] 2 , 3 , 13, 19, 36, 46, 65, 74, 75, 76, 77, 78, 96, 97, 107, 113, 156, 187, 191, 193, 195, 238, 246, 265, 274, 276, 299, 337 💬170. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 171 | Kaposi sarcoma-associated herpesvirus infection 💬 60 genes, 94 drugs (DrugBank) and 118 diseases |
HLA-A [6] HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G 💬Kaposi sarcoma-associated herpesvirus infection
|
Glatiramer acetate Glatiramer acetate 💬Kaposi sarcoma-associated herpesvirus infection
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 172 | Leishmaniasis 💬 40 genes, 68 drugs (DrugBank) and 102 diseases |
HLA-DMA [14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 💬Leishmaniasis
|
Glatiramer acetate Glatiramer acetate 💬Leishmaniasis
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 173 | Long-term depression 💬 14 genes, 23 drugs (DrugBank) and 34 diseases |
GRIA1 [3] GRIA1, GRIA2, GRIA3 💬
|
Topiramate Topiramate 💬Long-term depression
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 174 | Long-term potentiation 💬 18 genes, 36 drugs (DrugBank) and 86 diseases |
CACNA1C [3] CACNA1C, GRIA1, GRIA2 💬
|
Topiramate Topiramate 💬Long-term potentiation
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 175 | Long-term potentiation 💬 18 genes, 36 drugs (DrugBank) and 86 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Long-term potentiation |
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Long-term potentiation
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬175. Long-term potentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 176 | Long-term potentiation 💬 18 genes, 36 drugs (DrugBank) and 86 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Long-term potentiation |
Dextromethorphan Dextromethorphan 💬Long-term potentiation
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬175. Long-term potentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 177 | Long-term potentiation 💬 18 genes, 36 drugs (DrugBank) and 86 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Long-term potentiation |
Esketamine Esketamine 💬Long-term potentiation
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬177. Long-term potentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 178 | Long-term potentiation 💬 18 genes, 36 drugs (DrugBank) and 86 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Long-term potentiation |
Esketamine hydrochloride Esketamine hydrochloride 💬Long-term potentiation
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬177. Long-term potentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 179 | Long-term potentiation 💬 18 genes, 36 drugs (DrugBank) and 86 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Long-term potentiation |
Ketamine hydrochloride Ketamine hydrochloride 💬Long-term potentiation
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬179. Long-term potentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 180 | Long-term potentiation 💬 18 genes, 36 drugs (DrugBank) and 86 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Long-term potentiation |
Ketamine Ketamine 💬Long-term potentiation
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬179. Long-term potentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 181 | Longevity regulating pathway 💬 11 genes, 22 drugs (DrugBank) and 71 diseases |
INSR [1] INSR 💬Longevity regulating pathway
|
Insulin human Insulin human 💬Longevity regulating pathway
| Insulin human | 156 [1] 156 💬181. Longevity regulating pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 182 | Longevity regulating pathway - multiple species 💬 11 genes, 18 drugs (DrugBank) and 66 diseases |
INSR [1] INSR 💬Longevity regulating pathway - multiple species
|
Insulin human Insulin human 💬Longevity regulating pathway - multiple species
| Insulin human | 156 [1] 156 💬182. Longevity regulating pathway - multiple species
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 183 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬MAPK signaling pathway
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 184 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
INSR [1] INSR 💬MAPK signaling pathway
|
Insulin human Insulin human 💬MAPK signaling pathway
| Insulin human | 156 [1] 156 💬184. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 185 | Morphine addiction 💬 41 genes, 69 drugs (DrugBank) and 76 diseases |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬Morphine addiction
|
Topiramate Topiramate 💬Morphine addiction
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 186 | mTOR signaling pathway 💬 14 genes, 33 drugs (DrugBank) and 95 diseases |
INSR [1] INSR 💬mTOR signaling pathway
|
Insulin human Insulin human 💬mTOR signaling pathway
| Insulin human | 156 [1] 156 💬186. mTOR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 187 | Natural killer cell mediated cytotoxicity 💬 44 genes, 50 drugs (DrugBank) and 86 diseases |
HLA-A [5] HLA-A, HLA-B, HLA-C, HLA-E, HLA-G 💬Natural killer cell mediated cytotoxicity |
Glatiramer acetate Glatiramer acetate 💬Natural killer cell mediated cytotoxicity
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 188 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
ACHE [1] ACHE 💬Neuroactive ligand signaling
|
Donepezil hydrochloride Donepezil hydrochloride 💬Neuroactive ligand signaling
| Donepezil | 005 [8] 5 , 6 , 13, 46, 124, 127, 156, 206 💬188. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 189 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
ACHE [1] ACHE 💬Neuroactive ligand signaling
|
Donepezil Donepezil 💬Neuroactive ligand signaling
| Donepezil | 005 [8] 5 , 6 , 13, 46, 124, 127, 156, 206 💬188. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 190 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
|
Blarcamesine Blarcamesine 💬Neuroactive ligand signaling
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 191 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
|
Blarcamesine hydrochloride Blarcamesine hydrochloride 💬Neuroactive ligand signaling
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 192 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
DRD2 [2] DRD2, HTR1A 💬
|
Sarizotan hydrochloride Sarizotan hydrochloride 💬Neuroactive ligand signaling
| Sarizotan | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 193 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
DRD2 [2] DRD2, HTR2A 💬
|
Risperidone Risperidone 💬Neuroactive ligand signaling
| Risperidone | 008 [3] 8 , 156, 187 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 194 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
GABRA1 [25] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5 💬Neuroactive ligand signaling
|
Topiramate Topiramate 💬Neuroactive ligand signaling
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 195 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Neuroactive ligand signaling |
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Neuroactive ligand signaling
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬195. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 196 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Neuroactive ligand signaling |
Dextromethorphan Dextromethorphan 💬Neuroactive ligand signaling
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬195. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 197 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Neuroactive ligand signaling |
Esketamine Esketamine 💬Neuroactive ligand signaling
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬197. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 198 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Neuroactive ligand signaling |
Esketamine hydrochloride Esketamine hydrochloride 💬Neuroactive ligand signaling
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬197. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 199 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Neuroactive ligand signaling |
Ketamine hydrochloride Ketamine hydrochloride 💬Neuroactive ligand signaling
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬199. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 200 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Neuroactive ligand signaling |
Ketamine Ketamine 💬Neuroactive ligand signaling
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬199. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 201 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
|
Blarcamesine Blarcamesine 💬Neuroactive ligand-receptor interaction
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 202 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
|
Blarcamesine hydrochloride Blarcamesine hydrochloride 💬Neuroactive ligand-receptor interaction
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 203 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
CNR1 [2] CNR1, CNR2 💬
|
Cannabidiol Cannabidiol 💬Neuroactive ligand-receptor interaction
| Cannabidiol | 006 [20] 6 , 8 , 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬203. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 204 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
DRD2 [2] DRD2, HTR1A 💬
|
Sarizotan hydrochloride Sarizotan hydrochloride 💬Neuroactive ligand-receptor interaction
| Sarizotan | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 205 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
DRD2 [2] DRD2, HTR2A 💬
|
Risperidone Risperidone 💬Neuroactive ligand-receptor interaction
| Risperidone | 008 [3] 8 , 156, 187 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 206 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
GABRA1 [25] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5 💬Neuroactive ligand-receptor interaction
|
Topiramate Topiramate 💬Neuroactive ligand-receptor interaction
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 207 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
GHR [1] GHR 💬Neuroactive ligand-receptor interaction
|
Somatropin Somatropin 💬Neuroactive ligand-receptor interaction
| Somatotropin | 002 [28] 2 , 3 , 13, 19, 36, 46, 65, 74, 75, 76, 77, 78, 96, 97, 107, 113, 156, 187, 191, 193, 195, 238, 246, 265, 274, 276, 299, 337 💬207. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 208 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Neuroactive ligand-receptor interaction |
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Neuroactive ligand-receptor interaction
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬208. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 209 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Neuroactive ligand-receptor interaction |
Dextromethorphan Dextromethorphan 💬Neuroactive ligand-receptor interaction
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬208. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 210 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Neuroactive ligand-receptor interaction |
Esketamine Esketamine 💬Neuroactive ligand-receptor interaction
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬210. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 211 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Neuroactive ligand-receptor interaction |
Esketamine hydrochloride Esketamine hydrochloride 💬Neuroactive ligand-receptor interaction
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬210. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 212 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Neuroactive ligand-receptor interaction |
Ketamine hydrochloride Ketamine hydrochloride 💬Neuroactive ligand-receptor interaction
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬212. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 213 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Neuroactive ligand-receptor interaction |
Ketamine Ketamine 💬Neuroactive ligand-receptor interaction
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬212. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 214 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
S1PR1 [1] S1PR1 💬Neuroactive ligand-receptor interaction
|
Fingolimod hydrochloride Fingolimod hydrochloride 💬Neuroactive ligand-receptor interaction
| Fingolimod | 013 [3] 13, 14, 156 💬214. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 215 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
S1PR1 [1] S1PR1 💬Neuroactive ligand-receptor interaction
|
Fingolimod Fingolimod 💬Neuroactive ligand-receptor interaction
| Fingolimod | 013 [3] 13, 14, 156 💬214. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 216 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
S1PR1 [1] S1PR1 💬Neuroactive ligand-receptor interaction
|
Fingolimod lauryl sulfate Fingolimod lauryl sulfate 💬Neuroactive ligand-receptor interaction
| Fingolimod | 013 [3] 13, 14, 156 💬214. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 217 | Nicotine addiction 💬 30 genes, 36 drugs (DrugBank) and 47 diseases |
GABRA1 [20] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4 💬Nicotine addiction
|
Topiramate Topiramate 💬Nicotine addiction
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 218 | Nicotine addiction 💬 30 genes, 36 drugs (DrugBank) and 47 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Nicotine addiction |
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Nicotine addiction
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬218. Nicotine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 219 | Nicotine addiction 💬 30 genes, 36 drugs (DrugBank) and 47 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Nicotine addiction |
Dextromethorphan Dextromethorphan 💬Nicotine addiction
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬218. Nicotine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 220 | Nicotine addiction 💬 30 genes, 36 drugs (DrugBank) and 47 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Nicotine addiction |
Esketamine Esketamine 💬Nicotine addiction
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬220. Nicotine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 221 | Nicotine addiction 💬 30 genes, 36 drugs (DrugBank) and 47 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Nicotine addiction |
Esketamine hydrochloride Esketamine hydrochloride 💬Nicotine addiction
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬220. Nicotine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 222 | Nicotine addiction 💬 30 genes, 36 drugs (DrugBank) and 47 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Nicotine addiction |
Ketamine hydrochloride Ketamine hydrochloride 💬Nicotine addiction
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬222. Nicotine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 223 | Nicotine addiction 💬 30 genes, 36 drugs (DrugBank) and 47 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Nicotine addiction |
Ketamine Ketamine 💬Nicotine addiction
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬222. Nicotine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 224 | Nitrogen metabolism 💬 14 genes, 5 drugs (DrugBank) and 15 diseases |
CA2 [2] CA2, CA4 💬
|
Topiramate Topiramate 💬Nitrogen metabolism
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 225 | Non-alcoholic fatty liver disease 💬 23 genes, 52 drugs (DrugBank) and 95 diseases |
INSR [1] INSR 💬Non-alcoholic fatty liver disease
|
Insulin human Insulin human 💬Non-alcoholic fatty liver disease
| Insulin human | 156 [1] 156 💬225. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 226 | Ovarian steroidogenesis 💬 7 genes, 34 drugs (DrugBank) and 53 diseases |
INSR [1] INSR 💬Ovarian steroidogenesis
|
Insulin human Insulin human 💬Ovarian steroidogenesis
| Insulin human | 156 [1] 156 💬226. Ovarian steroidogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 227 | Oxytocin signaling pathway 💬 35 genes, 80 drugs (DrugBank) and 110 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Oxytocin signaling pathway
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 228 | Pancreatic secretion 💬 19 genes, 46 drugs (DrugBank) and 49 diseases |
CA2 [1] CA2 💬Pancreatic secretion
|
Topiramate Topiramate 💬Pancreatic secretion
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 229 | Pancreatic secretion 💬 19 genes, 46 drugs (DrugBank) and 49 diseases |
CHRM3 [1] CHRM3 💬Pancreatic secretion
|
Blarcamesine Blarcamesine 💬Pancreatic secretion
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 230 | Pancreatic secretion 💬 19 genes, 46 drugs (DrugBank) and 49 diseases |
CHRM3 [1] CHRM3 💬Pancreatic secretion
|
Blarcamesine hydrochloride Blarcamesine hydrochloride 💬Pancreatic secretion
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 231 | Parkinson disease 💬 24 genes, 76 drugs (DrugBank) and 68 diseases |
DRD2 [1] DRD2 💬Parkinson disease
|
Risperidone Risperidone 💬Parkinson disease
| Risperidone | 008 [3] 8 , 156, 187 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 232 | Parkinson disease 💬 24 genes, 76 drugs (DrugBank) and 68 diseases |
DRD2 [1] DRD2 💬Parkinson disease
|
Sarizotan hydrochloride Sarizotan hydrochloride 💬Parkinson disease
| Sarizotan | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 233 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
CACNA1C [8] CACNA1C, CACNA1D, CACNA1F, CACNA1S, GRIA1, GRIA2, GRIA3, GRIA4 💬Pathways of neurodegeneration - multiple diseases
|
Topiramate Topiramate 💬Pathways of neurodegeneration - multiple diseases
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 234 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
CHRM1 [4] CHRM1, CHRM3, CHRM5, SIGMAR1 💬
|
Blarcamesine Blarcamesine 💬Pathways of neurodegeneration - multiple diseases
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 235 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
CHRM1 [4] CHRM1, CHRM3, CHRM5, SIGMAR1 💬
|
Blarcamesine hydrochloride Blarcamesine hydrochloride 💬Pathways of neurodegeneration - multiple diseases
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 236 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Pathways of neurodegeneration - multiple diseases |
Esketamine Esketamine 💬Pathways of neurodegeneration - multiple diseases
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬236. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 237 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Pathways of neurodegeneration - multiple diseases |
Esketamine hydrochloride Esketamine hydrochloride 💬Pathways of neurodegeneration - multiple diseases
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬236. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 238 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Pathways of neurodegeneration - multiple diseases |
Ketamine hydrochloride Ketamine hydrochloride 💬Pathways of neurodegeneration - multiple diseases
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬238. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 239 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Pathways of neurodegeneration - multiple diseases |
Ketamine Ketamine 💬Pathways of neurodegeneration - multiple diseases
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬238. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 240 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬Pathways of neurodegeneration - multiple diseases
|
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Pathways of neurodegeneration - multiple diseases
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬240. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 241 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬Pathways of neurodegeneration - multiple diseases
|
Dextromethorphan Dextromethorphan 💬Pathways of neurodegeneration - multiple diseases
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬240. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 242 | Phagosome 💬 37 genes, 16 drugs (DrugBank) and 30 diseases |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬Phagosome
|
Glatiramer acetate Glatiramer acetate 💬Phagosome
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 243 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
INSR [1] INSR 💬Phospholipase D signaling pathway
|
Insulin human Insulin human 💬Phospholipase D signaling pathway
| Insulin human | 156 [1] 156 💬243. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 244 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 [2] CHRM1, CHRM2 💬
|
Blarcamesine Blarcamesine 💬PI3K-Akt signaling pathway
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 245 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
CHRM1 [2] CHRM1, CHRM2 💬
|
Blarcamesine hydrochloride Blarcamesine hydrochloride 💬PI3K-Akt signaling pathway
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 246 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
GHR [1] GHR 💬PI3K-Akt signaling pathway
|
Somatropin Somatropin 💬PI3K-Akt signaling pathway
| Somatotropin | 002 [28] 2 , 3 , 13, 19, 36, 46, 65, 74, 75, 76, 77, 78, 96, 97, 107, 113, 156, 187, 191, 193, 195, 238, 246, 265, 274, 276, 299, 337 💬246. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 247 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
INSR [1] INSR 💬PI3K-Akt signaling pathway
|
Insulin human Insulin human 💬PI3K-Akt signaling pathway
| Insulin human | 156 [1] 156 💬247. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 248 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Prion disease
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 249 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Prion disease |
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Prion disease
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬249. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 250 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Prion disease |
Dextromethorphan Dextromethorphan 💬Prion disease
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬249. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 251 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Prion disease |
Esketamine Esketamine 💬Prion disease
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬251. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 252 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Prion disease |
Esketamine hydrochloride Esketamine hydrochloride 💬Prion disease
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬251. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 253 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Prion disease |
Ketamine hydrochloride Ketamine hydrochloride 💬Prion disease
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬253. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 254 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Prion disease |
Ketamine Ketamine 💬Prion disease
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬253. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 255 | Proximal tubule bicarbonate reclamation 💬 7 genes, 7 drugs (DrugBank) and 16 diseases |
CA2 [2] CA2, CA4 💬
|
Topiramate Topiramate 💬Proximal tubule bicarbonate reclamation
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 256 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
CNR1 [1] CNR1 💬Rap1 signaling pathway
|
Cannabidiol Cannabidiol 💬Rap1 signaling pathway
| Cannabidiol | 006 [20] 6 , 8 , 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬256. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 257 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
DRD2 [1] DRD2 💬Rap1 signaling pathway
|
Risperidone Risperidone 💬Rap1 signaling pathway
| Risperidone | 008 [3] 8 , 156, 187 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 258 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
DRD2 [1] DRD2 💬Rap1 signaling pathway
|
Sarizotan hydrochloride Sarizotan hydrochloride 💬Rap1 signaling pathway
| Sarizotan | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 259 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
GRIN1 [3] GRIN1, GRIN2A, GRIN2B 💬
|
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Rap1 signaling pathway
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬259. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 260 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
GRIN1 [3] GRIN1, GRIN2A, GRIN2B 💬
|
Dextromethorphan Dextromethorphan 💬Rap1 signaling pathway
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬259. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 261 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
GRIN1 [3] GRIN1, GRIN2A, GRIN2B 💬
|
Esketamine Esketamine 💬Rap1 signaling pathway
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬261. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 262 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
GRIN1 [3] GRIN1, GRIN2A, GRIN2B 💬
|
Esketamine hydrochloride Esketamine hydrochloride 💬Rap1 signaling pathway
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬261. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 263 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
GRIN1 [3] GRIN1, GRIN2A, GRIN2B 💬
|
Ketamine hydrochloride Ketamine hydrochloride 💬Rap1 signaling pathway
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬263. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 264 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
GRIN1 [3] GRIN1, GRIN2A, GRIN2B 💬
|
Ketamine Ketamine 💬Rap1 signaling pathway
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬263. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 265 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
INSR [1] INSR 💬Rap1 signaling pathway
|
Insulin human Insulin human 💬Rap1 signaling pathway
| Insulin human | 156 [1] 156 💬265. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 266 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
GRIN1 [3] GRIN1, GRIN2A, GRIN2B 💬
|
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Ras signaling pathway
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬266. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 267 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
GRIN1 [3] GRIN1, GRIN2A, GRIN2B 💬
|
Dextromethorphan Dextromethorphan 💬Ras signaling pathway
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬266. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 268 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
GRIN1 [3] GRIN1, GRIN2A, GRIN2B 💬
|
Esketamine Esketamine 💬Ras signaling pathway
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬268. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 269 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
GRIN1 [3] GRIN1, GRIN2A, GRIN2B 💬
|
Esketamine hydrochloride Esketamine hydrochloride 💬Ras signaling pathway
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬268. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 270 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
GRIN1 [3] GRIN1, GRIN2A, GRIN2B 💬
|
Ketamine hydrochloride Ketamine hydrochloride 💬Ras signaling pathway
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬270. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 271 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
GRIN1 [3] GRIN1, GRIN2A, GRIN2B 💬
|
Ketamine Ketamine 💬Ras signaling pathway
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬270. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 272 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
INSR [1] INSR 💬Ras signaling pathway
|
Insulin human Insulin human 💬Ras signaling pathway
| Insulin human | 156 [1] 156 💬272. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 273 | Regulation of actin cytoskeleton 💬 35 genes, 82 drugs (DrugBank) and 81 diseases |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
|
Blarcamesine Blarcamesine 💬Regulation of actin cytoskeleton
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 274 | Regulation of actin cytoskeleton 💬 35 genes, 82 drugs (DrugBank) and 81 diseases |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
|
Blarcamesine hydrochloride Blarcamesine hydrochloride 💬Regulation of actin cytoskeleton
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 275 | Regulation of lipolysis in adipocytes 💬 13 genes, 71 drugs (DrugBank) and 79 diseases |
INSR [1] INSR 💬Regulation of lipolysis in adipocytes
|
Insulin human Insulin human 💬Regulation of lipolysis in adipocytes
| Insulin human | 156 [1] 156 💬275. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 276 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Renin secretion
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 277 | Retrograde endocannabinoid signaling 💬 34 genes, 65 drugs (DrugBank) and 68 diseases |
CACNA1C [24] CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4 💬Retrograde endocannabinoid signaling
|
Topiramate Topiramate 💬Retrograde endocannabinoid signaling
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 278 | Retrograde endocannabinoid signaling 💬 34 genes, 65 drugs (DrugBank) and 68 diseases |
CNR1 [1] CNR1 💬Retrograde endocannabinoid signaling
|
Cannabidiol Cannabidiol 💬Retrograde endocannabinoid signaling
| Cannabidiol | 006 [20] 6 , 8 , 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬278. Retrograde endocannabinoid signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 279 | Rheumatoid arthritis 💬 38 genes, 59 drugs (DrugBank) and 87 diseases |
HLA-DMA [14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 💬Rheumatoid arthritis
|
Glatiramer acetate Glatiramer acetate 💬Rheumatoid arthritis
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 280 | Salivary secretion 💬 21 genes, 74 drugs (DrugBank) and 72 diseases |
CHRM3 [1] CHRM3 💬Salivary secretion
|
Blarcamesine Blarcamesine 💬Salivary secretion
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 281 | Salivary secretion 💬 21 genes, 74 drugs (DrugBank) and 72 diseases |
CHRM3 [1] CHRM3 💬Salivary secretion
|
Blarcamesine hydrochloride Blarcamesine hydrochloride 💬Salivary secretion
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 282 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
CACNA1C [7] CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRB1, GABRB2, GABRB3 💬Serotonergic synapse
|
Topiramate Topiramate 💬Serotonergic synapse
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 283 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
HTR1A [1] HTR1A 💬Serotonergic synapse
|
Sarizotan hydrochloride Sarizotan hydrochloride 💬Serotonergic synapse
| Sarizotan | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 284 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
HTR2A [1] HTR2A 💬Serotonergic synapse
|
Risperidone Risperidone 💬Serotonergic synapse
| Risperidone | 008 [3] 8 , 156, 187 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 285 | Sphingolipid signaling pathway 💬 32 genes, 57 drugs (DrugBank) and 80 diseases |
S1PR1 [1] S1PR1 💬Sphingolipid signaling pathway
|
Fingolimod hydrochloride Fingolimod hydrochloride 💬Sphingolipid signaling pathway
| Fingolimod | 013 [3] 13, 14, 156 💬285. Sphingolipid signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 286 | Sphingolipid signaling pathway 💬 32 genes, 57 drugs (DrugBank) and 80 diseases |
S1PR1 [1] S1PR1 💬Sphingolipid signaling pathway
|
Fingolimod Fingolimod 💬Sphingolipid signaling pathway
| Fingolimod | 013 [3] 13, 14, 156 💬285. Sphingolipid signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 287 | Sphingolipid signaling pathway 💬 32 genes, 57 drugs (DrugBank) and 80 diseases |
S1PR1 [1] S1PR1 💬Sphingolipid signaling pathway
|
Fingolimod lauryl sulfate Fingolimod lauryl sulfate 💬Sphingolipid signaling pathway
| Fingolimod | 013 [3] 13, 14, 156 💬285. Sphingolipid signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 288 | Spinocerebellar ataxia 💬 18 genes, 29 drugs (DrugBank) and 74 diseases |
GRIA1 [3] GRIA1, GRIA2, GRIA3 💬
|
Topiramate Topiramate 💬Spinocerebellar ataxia
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 289 | Spinocerebellar ataxia 💬 18 genes, 29 drugs (DrugBank) and 74 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Spinocerebellar ataxia |
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Spinocerebellar ataxia
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬289. Spinocerebellar ataxia
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 290 | Spinocerebellar ataxia 💬 18 genes, 29 drugs (DrugBank) and 74 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Spinocerebellar ataxia |
Dextromethorphan Dextromethorphan 💬Spinocerebellar ataxia
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬289. Spinocerebellar ataxia
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 291 | Spinocerebellar ataxia 💬 18 genes, 29 drugs (DrugBank) and 74 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Spinocerebellar ataxia |
Esketamine Esketamine 💬Spinocerebellar ataxia
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬291. Spinocerebellar ataxia
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 292 | Spinocerebellar ataxia 💬 18 genes, 29 drugs (DrugBank) and 74 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Spinocerebellar ataxia |
Esketamine hydrochloride Esketamine hydrochloride 💬Spinocerebellar ataxia
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬291. Spinocerebellar ataxia
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 293 | Spinocerebellar ataxia 💬 18 genes, 29 drugs (DrugBank) and 74 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Spinocerebellar ataxia |
Ketamine hydrochloride Ketamine hydrochloride 💬Spinocerebellar ataxia
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬293. Spinocerebellar ataxia
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 294 | Spinocerebellar ataxia 💬 18 genes, 29 drugs (DrugBank) and 74 diseases |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬Spinocerebellar ataxia |
Ketamine Ketamine 💬Spinocerebellar ataxia
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬293. Spinocerebellar ataxia
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 295 | Staphylococcus aureus infection 💬 28 genes, 26 drugs (DrugBank) and 46 diseases |
HLA-DMA [14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 💬Staphylococcus aureus infection
|
Glatiramer acetate Glatiramer acetate 💬Staphylococcus aureus infection
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 296 | Systemic lupus erythematosus 💬 30 genes, 49 drugs (DrugBank) and 83 diseases |
GRIN2A [2] GRIN2A, GRIN2B 💬
|
Dextromethorphan hydrobromide Dextromethorphan hydrobromide 💬Systemic lupus erythematosus
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬296. Systemic lupus erythematosus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 297 | Systemic lupus erythematosus 💬 30 genes, 49 drugs (DrugBank) and 83 diseases |
GRIN2A [2] GRIN2A, GRIN2B 💬
|
Dextromethorphan Dextromethorphan 💬Systemic lupus erythematosus
| Dextromethorphan | 002 [10] 2 , 6 , 8 , 13, 21, 46, 85, 96, 97, 156 💬296. Systemic lupus erythematosus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 298 | Systemic lupus erythematosus 💬 30 genes, 49 drugs (DrugBank) and 83 diseases |
GRIN2A [2] GRIN2A, GRIN2B 💬
|
Esketamine Esketamine 💬Systemic lupus erythematosus
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬298. Systemic lupus erythematosus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 299 | Systemic lupus erythematosus 💬 30 genes, 49 drugs (DrugBank) and 83 diseases |
GRIN2A [2] GRIN2A, GRIN2B 💬
|
Esketamine hydrochloride Esketamine hydrochloride 💬Systemic lupus erythematosus
| Esketamine | 002 [7] 2 , 4 , 6 , 70, 96, 97, 156 💬298. Systemic lupus erythematosus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 300 | Systemic lupus erythematosus 💬 30 genes, 49 drugs (DrugBank) and 83 diseases |
GRIN2A [2] GRIN2A, GRIN2B 💬
|
Ketamine hydrochloride Ketamine hydrochloride 💬Systemic lupus erythematosus
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬300. Systemic lupus erythematosus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 301 | Systemic lupus erythematosus 💬 30 genes, 49 drugs (DrugBank) and 83 diseases |
GRIN2A [2] GRIN2A, GRIN2B 💬
|
Ketamine Ketamine 💬Systemic lupus erythematosus
| Ketamine | 006 [6] 6 , 13, 70, 113, 156, 215 💬300. Systemic lupus erythematosus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 302 | Systemic lupus erythematosus 💬 30 genes, 49 drugs (DrugBank) and 83 diseases |
HLA-DMA [14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 💬Systemic lupus erythematosus
|
Glatiramer acetate Glatiramer acetate 💬Systemic lupus erythematosus
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 303 | Taste transduction 💬 28 genes, 91 drugs (DrugBank) and 68 diseases |
CACNA1C [10] CACNA1C, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, SCN2A, SCN3A, SCN9A 💬Taste transduction
|
Topiramate Topiramate 💬Taste transduction
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 304 | Taste transduction 💬 28 genes, 91 drugs (DrugBank) and 68 diseases |
CHRM3 [1] CHRM3 💬Taste transduction
|
Blarcamesine Blarcamesine 💬Taste transduction
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 305 | Taste transduction 💬 28 genes, 91 drugs (DrugBank) and 68 diseases |
CHRM3 [1] CHRM3 💬Taste transduction
|
Blarcamesine hydrochloride Blarcamesine hydrochloride 💬Taste transduction
| Blarcamesine | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 306 | Taste transduction 💬 28 genes, 91 drugs (DrugBank) and 68 diseases |
HTR1A [1] HTR1A 💬Taste transduction
|
Sarizotan hydrochloride Sarizotan hydrochloride 💬Taste transduction
| Sarizotan | 006 [2] 6 , 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 307 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 56 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Lovastatin Lovastatin 💬Terpenoid backbone biosynthesis
| Lovastatin | 006 [11] 6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬307. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 308 | Th1 and Th2 cell differentiation 💬 46 genes, 51 drugs (DrugBank) and 77 diseases |
HLA-DMA [14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 💬Th1 and Th2 cell differentiation
|
Glatiramer acetate Glatiramer acetate 💬Th1 and Th2 cell differentiation
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 309 | Th17 cell differentiation 💬 56 genes, 80 drugs (DrugBank) and 108 diseases |
HLA-DMA [14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 💬Th17 cell differentiation
|
Glatiramer acetate Glatiramer acetate 💬Th17 cell differentiation
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 310 | Thermogenesis 💬 17 genes, 31 drugs (DrugBank) and 83 diseases |
CNR1 [1] CNR1 💬Thermogenesis
|
Cannabidiol Cannabidiol 💬Thermogenesis
| Cannabidiol | 006 [20] 6 , 8 , 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬310. Thermogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 311 | Tight junction 💬 13 genes, 36 drugs (DrugBank) and 50 diseases |
CACNA1D [1] CACNA1D 💬Tight junction
|
Topiramate Topiramate 💬Tight junction
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 312 | Toxoplasmosis 💬 41 genes, 49 drugs (DrugBank) and 76 diseases |
HLA-DMA [14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 💬Toxoplasmosis
|
Glatiramer acetate Glatiramer acetate 💬Toxoplasmosis
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 313 | Transcriptional misregulation in cancer 💬 28 genes, 60 drugs (DrugBank) and 79 diseases |
GRIA3 [1] GRIA3 💬Transcriptional misregulation in cancer
|
Topiramate Topiramate 💬Transcriptional misregulation in cancer
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 314 | Tuberculosis 💬 66 genes, 73 drugs (DrugBank) and 98 diseases |
HLA-DMA [14] HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 💬Tuberculosis
|
Glatiramer acetate Glatiramer acetate 💬Tuberculosis
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 315 | Type I diabetes mellitus 💬 32 genes, 25 drugs (DrugBank) and 70 diseases |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬Type I diabetes mellitus
|
Glatiramer acetate Glatiramer acetate 💬Type I diabetes mellitus
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 316 | Type II diabetes mellitus 💬 14 genes, 42 drugs (DrugBank) and 94 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Topiramate Topiramate 💬Type II diabetes mellitus
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 317 | Type II diabetes mellitus 💬 14 genes, 42 drugs (DrugBank) and 94 diseases |
INSR [1] INSR 💬Type II diabetes mellitus
|
Insulin human Insulin human 💬Type II diabetes mellitus
| Insulin human | 156 [1] 156 💬317. Type II diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 318 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Vascular smooth muscle contraction
| Topiramate | 006 [5] 6 , 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 319 | Viral carcinogenesis 💬 32 genes, 31 drugs (DrugBank) and 58 diseases |
HLA-A [6] HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G 💬Viral carcinogenesis
|
Glatiramer acetate Glatiramer acetate 💬Viral carcinogenesis
| Glatiramer | 013 [3] 13, 96, 156 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 320 | Viral myocarditis 💬 34 genes, 27 drugs (DrugBank) and 52 diseases |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬Viral myocarditis
|
Glatiramer acetate Glatiramer acetate 💬Viral myocarditis
| Glatiramer | 013 [3] 13, 96, 156 💬
|
Adherens junction
12 genes, 24 drugs (DrugBank) and 29 diseases
Adrenergic signaling in cardiomyocytes
31 genes, 84 drugs (DrugBank) and 76 diseases
Alcoholism
29 genes, 81 drugs (DrugBank) and 60 diseases
Aldosterone synthesis and secretion
20 genes, 41 drugs (DrugBank) and 61 diseases
Aldosterone-regulated sodium reabsorption
13 genes, 17 drugs (DrugBank) and 30 diseases
Allograft rejection
31 genes, 26 drugs (DrugBank) and 60 diseases
Alzheimer disease
59 genes, 132 drugs (DrugBank) and 129 diseases
Amphetamine addiction
25 genes, 58 drugs (DrugBank) and 92 diseases
AMPK signaling pathway
16 genes, 56 drugs (DrugBank) and 95 diseases
Amyotrophic lateral sclerosis
38 genes, 55 drugs (DrugBank) and 109 diseases
Antigen processing and presentation
26 genes, 17 drugs (DrugBank) and 61 diseases
Arrhythmogenic right ventricular cardiomyopathy
15 genes, 30 drugs (DrugBank) and 28 diseases
Asthma
21 genes, 25 drugs (DrugBank) and 58 diseases
Autoimmune thyroid disease
42 genes, 18 drugs (DrugBank) and 37 diseases
Bile secretion
14 genes, 36 drugs (DrugBank) and 61 diseases
Calcium signaling pathway
86 genes, 214 drugs (DrugBank) and 143 diseases
cAMP signaling pathway
66 genes, 189 drugs (DrugBank) and 130 diseases
Carbohydrate digestion and absorption
13 genes, 21 drugs (DrugBank) and 33 diseases
Cardiac muscle contraction
17 genes, 20 drugs (DrugBank) and 25 diseases
Cell adhesion molecules
43 genes, 34 drugs (DrugBank) and 43 diseases
Cellular senescence
34 genes, 46 drugs (DrugBank) and 96 diseases
cGMP-PKG signaling pathway
49 genes, 132 drugs (DrugBank) and 124 diseases
Chemical carcinogenesis - receptor activation
39 genes, 135 drugs (DrugBank) and 134 diseases
Cholinergic synapse
32 genes, 64 drugs (DrugBank) and 81 diseases
Circadian entrainment
23 genes, 39 drugs (DrugBank) and 55 diseases
Cocaine addiction
15 genes, 66 drugs (DrugBank) and 54 diseases
Collecting duct acid secretion
3 genes, 11 drugs (DrugBank) and 34 diseases
Cortisol synthesis and secretion
15 genes, 36 drugs (DrugBank) and 63 diseases
Cushing syndrome
24 genes, 55 drugs (DrugBank) and 71 diseases
Cytokine-cytokine receptor interaction
89 genes, 142 drugs (DrugBank) and 110 diseases
Diabetic cardiomyopathy
28 genes, 48 drugs (DrugBank) and 79 diseases
Dilated cardiomyopathy
24 genes, 61 drugs (DrugBank) and 88 diseases
Dopaminergic synapse
31 genes, 102 drugs (DrugBank) and 104 diseases
Efferocytosis
29 genes, 74 drugs (DrugBank) and 93 diseases
Endocytosis
22 genes, 37 drugs (DrugBank) and 54 diseases
Epstein-Barr virus infection
67 genes, 90 drugs (DrugBank) and 82 diseases
FoxO signaling pathway
25 genes, 43 drugs (DrugBank) and 60 diseases
GABAergic synapse
29 genes, 43 drugs (DrugBank) and 55 diseases
Gap junction
26 genes, 97 drugs (DrugBank) and 82 diseases
Gastric acid secretion
14 genes, 55 drugs (DrugBank) and 63 diseases
Glutamatergic synapse
23 genes, 30 drugs (DrugBank) and 81 diseases
Glycerophospholipid metabolism
1 gene, 7 drugs (DrugBank) and 14 diseases
GnRH secretion
22 genes, 47 drugs (DrugBank) and 56 diseases
GnRH signaling pathway
16 genes, 40 drugs (DrugBank) and 42 diseases
Graft-versus-host disease
28 genes, 25 drugs (DrugBank) and 64 diseases
Growth hormone synthesis, secretion and action
23 genes, 49 drugs (DrugBank) and 100 diseases
Hematopoietic cell lineage
53 genes, 95 drugs (DrugBank) and 101 diseases
Herpes simplex virus 1 infection
70 genes, 80 drugs (DrugBank) and 107 diseases
HIF-1 signaling pathway
26 genes, 56 drugs (DrugBank) and 87 diseases
Hormone signaling
66 genes, 211 drugs (DrugBank) and 153 diseases
Human cytomegalovirus infection
64 genes, 114 drugs (DrugBank) and 130 diseases
Human immunodeficiency virus 1 infection
50 genes, 57 drugs (DrugBank) and 95 diseases
Human papillomavirus infection
51 genes, 106 drugs (DrugBank) and 115 diseases
Human T-cell leukemia virus 1 infection
59 genes, 74 drugs (DrugBank) and 96 diseases
Huntington disease
26 genes, 39 drugs (DrugBank) and 87 diseases
Hypertrophic cardiomyopathy
27 genes, 57 drugs (DrugBank) and 90 diseases
Inflammatory bowel disease
37 genes, 46 drugs (DrugBank) and 70 diseases
Inflammatory mediator regulation of TRP channels
25 genes, 53 drugs (DrugBank) and 65 diseases
Influenza A
65 genes, 78 drugs (DrugBank) and 98 diseases
Insulin resistance
19 genes, 38 drugs (DrugBank) and 100 diseases
Insulin secretion
15 genes, 48 drugs (DrugBank) and 51 diseases
Insulin signaling pathway
12 genes, 28 drugs (DrugBank) and 71 diseases
Intestinal immune network for IgA production
33 genes, 40 drugs (DrugBank) and 51 diseases
JAK-STAT signaling pathway
61 genes, 113 drugs (DrugBank) and 123 diseases
Kaposi sarcoma-associated herpesvirus infection
60 genes, 94 drugs (DrugBank) and 118 diseases
Leishmaniasis
40 genes, 68 drugs (DrugBank) and 102 diseases
Long-term depression
14 genes, 23 drugs (DrugBank) and 34 diseases
Long-term potentiation
18 genes, 36 drugs (DrugBank) and 86 diseases
Longevity regulating pathway
11 genes, 22 drugs (DrugBank) and 71 diseases
Longevity regulating pathway - multiple species
11 genes, 18 drugs (DrugBank) and 66 diseases
MAPK signaling pathway
65 genes, 98 drugs (DrugBank) and 109 diseases
Morphine addiction
41 genes, 69 drugs (DrugBank) and 76 diseases
mTOR signaling pathway
14 genes, 33 drugs (DrugBank) and 95 diseases
Natural killer cell mediated cytotoxicity
44 genes, 50 drugs (DrugBank) and 86 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 117 diseases
Neuroactive ligand-receptor interaction
158 genes, 364 drugs (DrugBank) and 173 diseases
Nicotine addiction
30 genes, 36 drugs (DrugBank) and 47 diseases
Nitrogen metabolism
14 genes, 5 drugs (DrugBank) and 15 diseases
Non-alcoholic fatty liver disease
23 genes, 52 drugs (DrugBank) and 95 diseases
Ovarian steroidogenesis
7 genes, 34 drugs (DrugBank) and 53 diseases
Oxytocin signaling pathway
35 genes, 80 drugs (DrugBank) and 110 diseases
Pancreatic secretion
19 genes, 46 drugs (DrugBank) and 49 diseases
Parkinson disease
24 genes, 76 drugs (DrugBank) and 68 diseases
Pathways of neurodegeneration - multiple diseases
63 genes, 138 drugs (DrugBank) and 132 diseases
Phagosome
37 genes, 16 drugs (DrugBank) and 30 diseases
Phospholipase D signaling pathway
23 genes, 59 drugs (DrugBank) and 82 diseases
PI3K-Akt signaling pathway
85 genes, 142 drugs (DrugBank) and 131 diseases
Prion disease
41 genes, 74 drugs (DrugBank) and 114 diseases
Proximal tubule bicarbonate reclamation
7 genes, 7 drugs (DrugBank) and 16 diseases
Rap1 signaling pathway
45 genes, 113 drugs (DrugBank) and 98 diseases
Ras signaling pathway
37 genes, 64 drugs (DrugBank) and 70 diseases
Regulation of actin cytoskeleton
35 genes, 82 drugs (DrugBank) and 81 diseases
Regulation of lipolysis in adipocytes
13 genes, 71 drugs (DrugBank) and 79 diseases
Renin secretion
28 genes, 87 drugs (DrugBank) and 113 diseases
Retrograde endocannabinoid signaling
34 genes, 65 drugs (DrugBank) and 68 diseases
Rheumatoid arthritis
38 genes, 59 drugs (DrugBank) and 87 diseases
Salivary secretion
21 genes, 74 drugs (DrugBank) and 72 diseases
Serotonergic synapse
39 genes, 122 drugs (DrugBank) and 83 diseases
Sphingolipid signaling pathway
32 genes, 57 drugs (DrugBank) and 80 diseases
Spinocerebellar ataxia
18 genes, 29 drugs (DrugBank) and 74 diseases
Staphylococcus aureus infection
28 genes, 26 drugs (DrugBank) and 46 diseases
Systemic lupus erythematosus
30 genes, 49 drugs (DrugBank) and 83 diseases
Taste transduction
28 genes, 91 drugs (DrugBank) and 68 diseases
Terpenoid backbone biosynthesis
4 genes, 14 drugs (DrugBank) and 56 diseases
Th1 and Th2 cell differentiation
46 genes, 51 drugs (DrugBank) and 77 diseases
Th17 cell differentiation
56 genes, 80 drugs (DrugBank) and 108 diseases
Thermogenesis
17 genes, 31 drugs (DrugBank) and 83 diseases
Tight junction
13 genes, 36 drugs (DrugBank) and 50 diseases
Toxoplasmosis
41 genes, 49 drugs (DrugBank) and 76 diseases
Transcriptional misregulation in cancer
28 genes, 60 drugs (DrugBank) and 79 diseases
Tuberculosis
66 genes, 73 drugs (DrugBank) and 98 diseases
Type I diabetes mellitus
32 genes, 25 drugs (DrugBank) and 70 diseases
Type II diabetes mellitus
14 genes, 42 drugs (DrugBank) and 94 diseases
Vascular smooth muscle contraction
32 genes, 92 drugs (DrugBank) and 71 diseases
Viral carcinogenesis
32 genes, 31 drugs (DrugBank) and 58 diseases
Viral myocarditis
34 genes, 27 drugs (DrugBank) and 52 diseases
